表紙
市場調查報告書

睪酮(睪丸激素)替代療法 (TRT)的全球市場:2019年∼2023年

Global Testosterone Replacement Therapy Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 365949
出版日期 內容資訊 英文 102 Pages
訂單完成後即時交付
價格
Back to Top
睪酮(睪丸激素)替代療法 (TRT)的全球市場:2019年∼2023年 Global Testosterone Replacement Therapy Market 2019-2023
出版日期: 2018年12月05日內容資訊: 英文 102 Pages
簡介

本報告提供全球睪酮(睪丸激素)替代療法 (TRT) 市場相關調查分析,市場概要,各市場區隔考察,各地區考察,推動市場的要素,主要企業等相關之整體分析、彙整。

第1章 摘要整理

第2章 本報告的調查範圍

第3章 市場形勢

  • 市場生態系統
  • 市場區隔分析
  • 市場特徵

第4章 開發平台分析

  • 開發平台分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模與預測

第6章 波特的五力分析

第7章 各產品的市場分類

  • 各產品的市場分類
  • 各產品比較
  • 注射 - 市場規模與預測
  • 局部 - 市場規模與預測
  • 其他 - 市場規模與預測
  • 市場機會

第8章 客戶形勢

第9章 地區形勢

  • 地區分類
  • 地區比較
  • 南北美洲 - 市場規模與預測
  • 歐洲、中東、非洲地區 - 市場規模與預測
  • 亞太地區 - 市場規模與預測
  • 主要國家
  • 市場機會

第10章 市場成長因素與課題

  • 市場成長因素
  • 市場課題

第11章 市場趨勢

  • 市場趨勢

第12章 業者情勢

  • 概要
  • 創造性破壞狀況

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • AbbVie
  • Bayer
  • Endo Pharmaceuticals

第14章 附錄

  • 調查手法
  • 簡稱清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR30353

About this market:

Increased awareness about hypogonadism among the public and primary care physicians will drive the market. Globally, different organizations are working on initiatives to increase patient awareness of hypogonadism and available treatment options. The vendors are actively taking part in the awareness campaign to educate the population about the diagnoses and treatment for hypogonadism. Also, organizations are increase awareness about hypogonadism among medical professionals. They release clinical practice guidelines on testosterone therapy. The testosterone replacement therapy market growth at a CAGR of more than (2%) during the forecast period.

Market Overview:

High prevalence of testosterone deficiency

High prevalence of hypogonadism is related to the social stigma associated with hypogonadism among young men. Hence, demographic tends toward the increasing geriatric population and improved life expectancy result in the increased risk for incidence and prevalence for hypogonadism.

Adverse effects of testosterone replacement therapy

Testosterone replacement therapy is being approved by the FDA and is indicated to treat disorders associated with low levels of testosterone. Therefore, the adverse effects associated with testosterone replacement therapies can decrease [patient compliances, thereby leading to a decline in the growth of the market.

For the detailed list of factors that will drive and challenge the growth of the testosterone replacement therapy market during the 2019-2023, view our report.

Competitive Landscape:

The global testosterone replacement therapy market is extremely concentrated since the market has a few vendors that offer limited products with presence of few global and local vendors. The market has witnessed a rise in novel therapeutics approaches which have a positive impact on the market growth. The vendors are increasingly competing against each other based on factors such as innovation, price, operational cost, and product quality. To maintain their market positions, the vendors in this testosterone replacement therapy are focusing on adopting various strategies and this will in turn, help them to strengthen and restructure their activities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market segmentation analysis
  • Market characteristics

PART 04: PIPELINE ANALYSIS

  • Pipeline analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Injections - Market size and forecast 2018-2023
  • Topicals - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Market trends

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie
  • Bayer
  • Endo Pharmaceuticals

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Years in consideration
  • Exhibit 02: Global endocrinology drugs market
  • Exhibit 03: Segments of global endocrinology drugs market
  • Exhibit 04: Market segments
  • Exhibit 05: Market characteristics
  • Exhibit 06: Late-stage pipeline analysis drugs for testosterone deficiency
  • Exhibit 07: Market definition - Inclusions and exclusions checklist
  • Exhibit 08: Market size 2018
  • Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 11: Five forces analysis 2018
  • Exhibit 12: Five forces analysis 2023
  • Exhibit 13: Bargaining power of buyers
  • Exhibit 14: Bargaining power of suppliers
  • Exhibit 15: Threat of new entrants
  • Exhibit 16: Threat of substitutes
  • Exhibit 17: Threat of rivalry
  • Exhibit 18: Market condition - Five forces 2018
  • Exhibit 19: Product - Market share 2018-2023 (%)
  • Exhibit 20: Comparison by product
  • Exhibit 21: Injections - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Injections - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Topicals - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Topicals - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 26: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 27: Market opportunity by product
  • Exhibit 28: Customer landscape
  • Exhibit 29: Market share by geography 2018-2023 (%)
  • Exhibit 30: Geographic comparison
  • Exhibit 31: Americas - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Americas - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: EMEA - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: EMEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Decision framework
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: AbbVie - Vendor overview
  • Exhibit 47: AbbVie - Business segments
  • Exhibit 48: AbbVie - Organizational developments
  • Exhibit 49: AbbVie - Geographic focus
  • Exhibit 50: AbbVie - Key offerings
  • Exhibit 51: Bayer - Vendor overview
  • Exhibit 52: Bayer - Business segments
  • Exhibit 53: Bayer - Organizational developments
  • Exhibit 54: Bayer - Geographic focus
  • Exhibit 55: Bayer - Segment focus
  • Exhibit 56: Bayer - Key offerings
  • Exhibit 57: Endo Pharmaceuticals - Vendor overview
  • Exhibit 58: Endo Pharmaceuticals - Business segments
  • Exhibit 59: Endo Pharmaceuticals - Organizational developments
  • Exhibit 60: Endo Pharmaceuticals - Geographic focus
  • Exhibit 61: Endo Pharmaceuticals - Segment focus
  • Exhibit 62: Endo Pharmaceuticals - Key offerings
  • Exhibit 63: Validation techniques employed for market sizing
  • Exhibit 64: List of abbreviations
Back to Top